Overview
Tirzepatide is a 39-amino acid synthetic peptide that functions as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It was designed to combine the complementary metabolic actions of two distinct incretin hormones into a single molecule. Unlike monoagonist GLP-1 receptor agonists, tirzepatide's simultaneous engagement of the GIP receptor contributes additional and synergistic effects on glucose homeostasis, adipose tissue biology, and energy balance in research models.
Mechanism
Tirzepatide binds to and activates both the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R) with high affinity. GIP receptor activation stimulates glucose-dependent insulin secretion, suppresses glucagon, and has been shown in preclinical models to directly influence adipocyte lipid metabolism and reduce adipose tissue inflammation. GLP-1 receptor activation independently stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and engages central appetite-regulating pathways in the hypothalamus and brainstem. The dual mechanism produces additive or synergistic effects on insulin sensitivity and energy expenditure compared to GLP-1 receptor agonism alone.
Research Areas
-
Metabolic Research
Tirzepatide has been studied extensively for its effects on glucose homeostasis, insulin secretion, and glucagon suppression across a range of metabolic research models.
-
Adipose Tissue Research
Research has examined GIP receptor signaling in adipocytes and its role in lipid uptake, storage, and mobilization, with tirzepatide used as a dual-receptor probe.
-
Appetite & Energy Balance Research
Studies have explored the combined effects of GIP and GLP-1 receptor co-activation on hypothalamic appetite circuits and energy expenditure in preclinical models.
-
Cardiovascular Research
Preclinical research has examined the effects of dual incretin receptor agonism on cardiovascular risk markers, including blood pressure, lipid profiles, and inflammatory mediators.
Storage
Store lyophilized at -20°C. Reconstitute with sterile bacteriostatic water. Once reconstituted, store at 4°C and use within 28 days. Avoid repeated freeze-thaw cycles.